🔗 Share this article

Treasury head Rachel Reeves has stated she is planning "focused measures to deal with cost of living pressures" in next month's financial statement.

In comments to the BBC, she emphasized that lowering price rises is a joint responsibility of both the administration and the central bank.

The United Kingdom's price growth is forecast to be the most elevated among the Group of Seven industrialized countries this calendar year and next.

Possible Energy Bill Interventions

It is understood the government could take action to reduce energy bills, such as by cutting the present 5% rate of VAT applied on energy.

Another option is to cut some of the regulatory levies presently included in household expenses.

Fiscal Limitations and Analyst Predictions

The government will obtain the next draft from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much room there is for such measures.

The view from most experts is that the Chancellor will have to introduce tax rises or spending cuts in order to adhere to her declared borrowing rules.

Previously on the same day, estimates indicated there was a twenty-two billion pound shortfall for the Treasury chief to address, which is at the lower end of expectations.

"It is a joint responsibility between the central bank and the government to further reduce some of the drivers of inflation," Reeves told reporters in the US capital, at the annual meetings of the International Monetary Fund and global financial institution.

Revenue Pledges and Global Issues

While a great deal of the attention has been on likely tax rises, the Treasury chief said the latest data from the fiscal watchdog had not altered her vow to campaign commitments not to increase tax levels on income tax, sales tax or National Insurance.

She blamed an "unpredictable world" with increasing geopolitical and trade concerns for the Budget revenue measures, probably to be focused on those "with the broadest shoulders."

Global Economic Disputes

Referring to apprehensions about the United Kingdom's commercial links with the Asian nation she said: "Our national security always take priority."

Last week's statement by Chinese authorities to increase export controls on critical minerals and other materials that are essential for advanced tech manufacturing led American leader Donald Trump to suggest an further 100% tariff on imports from China, raising the risk of an all-out trade war between the two largest economies.

The American finance chief called the Chinese action "economic coercion" and "a global supply chain control attempt."

Asked about considering the American proposal to participate in its dispute with the Asian nation, the Chancellor said she was "extremely troubled" by China's measures and urged the Chinese government "not to put up barriers and limit trade."

She said the decision was "bad for the world economy and creates further challenges."

"In my view there are areas where we should challenge Chinese policies, but there are also important opportunities to export to China's economy, including financial services and other areas of the economic system. We've got to get that balance correct."

The chancellor also confirmed she was collaborating with G7 counterparts "on our own critical minerals strategy, so that we are less reliant."

NHS Medicine Pricing and Funding

Reeves also acknowledged that the price the NHS spends on pharmaceuticals could go up as a result of current talks with the US government and its pharmaceutical firms, in return for lower tariffs and investment.

A number of the biggest global drug companies have said in recent statements that they are either pausing or abandoning projects in the United Kingdom, with several blaming the modest returns they are obtaining.

Recently, the Science Minister said the cost the NHS spends on medicines would have to rise to stop firms and pharmaceutical investment departing from the United Kingdom.

Reeves told media: "It has been observed as a result of the payment system, that clinical trials, recent pharmaceuticals have not been available in the UK in the way that they are in other EU nations."

"Our aim is to make sure that people receiving care from the National Health Service are able to access the best life-saving drugs in the globe. And so we are examining these issues, and... looking to obtain increased capital into the UK."